drugset / Trial / NCT01294176

Lipoic Acid as a Treatment for Acute Optic Neuritis

NCT01294176

Phase 1 Completed 31 enrolled Oregon Health and Science University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if oral lipoic acid can safely help relieve permanent optic nerve injury in patients diagnosed with acute optic neuritis. It will also explore how the body absorbs and breaks down the study drug, and what effects it has on the immune system.

Timeline

Start
2011-01
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator alpha-lipoic acid Small molecule 1200 mg Oral

Indications